KRAIG BIOCRAFT LABS INC KBLB

$0.09 -1.79% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-13 View →
10-Q 10-Q 2026-05-14 View →
10-K 10-K 2026-03-30 View →
8-K 8-K 2026-02-18 View →
10-Q 10-Q 2025-11-12 View →
10-Q 10-Q 2025-08-14 View →
4 Insider transaction 2025-05-29 View →
10-Q Quarterly report 2025-05-15 View →
4 Insider transaction 2025-04-10 View →
4 Insider transaction 2025-04-08 View →
10-K Annual report 2025-03-28 View →
4 Insider transaction 2025-03-24 View →
S-1 IPO registration 2025-02-07 View →
8-K Current report (material event) 2025-01-21 View →
10-Q Quarterly report 2024-11-13 View →
10-Q Quarterly report 2024-08-14 View →
10-Q Quarterly report 2024-05-14 View →
10-K Annual report 2024-04-01 View →
8-K Current report (material event) 2024-04-01 View →
10-Q Quarterly report 2023-11-13 View →
10-Q Quarterly report 2023-08-14 View →
10-Q Quarterly report 2023-05-12 View →
10-K Annual report 2023-03-29 View →
4 Insider transaction 2023-02-17 View →
10-Q Quarterly report 2022-11-14 View →
10-Q Quarterly report 2022-08-01 View →
4 Insider transaction 2022-07-21 View →
4 Insider transaction 2022-07-19 View →
4 Insider transaction 2022-07-15 View →
4 Insider transaction 2022-07-13 View →
4 Insider transaction 2022-07-11 View →
4 Insider transaction 2022-07-07 View →
4 Insider transaction 2022-07-01 View →
4 Insider transaction 2022-06-29 View →
4 Insider transaction 2022-06-24 View →
4 Insider transaction 2022-06-23 View →
4 Insider transaction 2022-06-21 View →
4 Insider transaction 2022-06-17 View →
4 Insider transaction 2022-06-10 View →
4 Insider transaction 2022-06-08 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$0.09
Market Cap
52-Week Range
$0.07 $0.16
Average Volume
732K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.